Crenezumab (Anti-Amyloid Beta)
A2764
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameCrenezumab (Anti-Amyloid Beta)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionCrenezumab (Anti-Amyloid Beta) is a fully humanized immunoglobulin (Ig) G4 monoclonal antibody that targets amyloid beta (Abeta) with potential for use in Alzheimers disease research. MW: 143.58 kD.
- Storage Instruction-20°C
- UNSPSC12352203